products

High purity Enrofloxacin antibiotic medicine api powder for dogs 93106-60-6

Basic Information
Place of Origin: Shaanxi, China
Brand Name: Accenturebio
Certification: GMP, ISO, SGS, QS, HALAL, HPLC
Model Number: Accenture-Eenrofloxacin for dogs
Minimum Order Quantity: 25kg
Price: $28-$37 per kilogram
Packaging Details: 1-25kg bag, 25kg drum
Delivery Time: 1-3 work days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 5300 kg per month
Detail Information
Product Name: Enrofloxacin For Dogs EINECS No.: 93106-60-6
Cas No.: 618-911-2 Color: Off-white To Light Yellow
Sample: Available Molecular Formula: C19H22FN3O3
Brand: Accenturebio Dosage Form: Powder
High Light:

ciprofloxacin urinary tract infection

,

neomycin sulfate powder


Product Description

High purity Enrofloxacin antibiotic medicine api powder for dogs 93106-60-6

Enrofloxacin for dogs Introduction:

1) Product Name: Enrofloxacin for dogs

2) Active ingredients: enrofloxacin

3) Specification: 99%min

4) Test method: TLC

5) Appearance: Light yellow to white crystalline powder

6) Introduction:

Enrofloxacin is a synthetic third generation quinolone antibiotic, also known as ethyl ciprofloxacin. It was approved by FDA on October 4, 1996 and is a special quinolone antibiotic for livestock, poultry and aquatic products. It can bind to bacterial DNA cyclotylase subunit A, thus inhibiting the cleavage and ligation of enzymes, preventing the replication of bacterial DNA and showing antimicrobial effect.

Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. Enrofloxacin on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

Enrofloxacin for dogs Function

1. Ciprofloxacin for dogs which is used to treat a wide variety of infections, including infections of bones and joints, endocarditis,gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections,prostatitis, anthrax, and chancroid;

2. Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent;

3. Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa.

For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Diseases Society of America for the treatment of community-acquired abdominal infections in adults.It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis,certain types of endocarditis, certain skin infections, and prosthetic joint infections.

Enrofloxacin for dogs Application:

1. Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism. 

2. Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism.

3. Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Enrofloxacin for dogs Specification:

PRODUCT NAME Enrofloxacin
CAS no. 93106-60-6 Quantity 5600kgs
Storage Sealed and kept in a dry place,Low temperature
Items of analysis Specification Results
Appearance Yellowish or light orange yellow crystalline powder Complies
Melting point 221℃~226℃ 223.5℃~225.5℃
Identification IR Complies
  HPLC Complies
Appearance of solution Solution is clear, solution is not more intensely colored than reference solution Complies
Fluoroquinolonic acid ≤0.2% <0.2%
Related substances Ciprofloxacin ≤0.5% 0.06%
  Other individual impurities ≤0.3% 0.19% (RRT: 1.8)
  Total impurities ≤0.7% 0.29%
Heavy metal ≤20% <20%
Residue on ignition ≤0.2% 0.03%
Loss on drying ≤0.5% 0.04%
Assay ≥99.0% 99.4%
Conclusion Conforms with enterprise standards

High purity Enrofloxacin antibiotic medicine api powder for dogs 93106-60-6 0High purity Enrofloxacin antibiotic medicine api powder for dogs 93106-60-6 1

Contact Details
accenturebio3

Phone Number : 8618402999820

WhatsApp : +8618402999820